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ABSTRACT
  
     Evaluation of the factors associated with treatment process of leukemia and comparison with current 
related approaches in developed countries can present a good indicator to assess the weak and strong points 
in healthcare system of our country in leukemia treatment. The objective of this research is general and 
specific description of the challenges and shortcomings in Iranian healthcare system and monitoring of 
hematologic malignancies as well as comparison with developed countries. Our study is a descriptive-cross-
sectional study. 100 hemato-oncologist , pathologists, and faculty members throughout the country were 
selected by random cluster sampling. Data collected using questionnaires with Cronbach's alpha coefficient 
of 0.76 . SPSS and Chi-square test were used for data analysis. According to the specialists, lack of 
advanced diagnostic facilities as well as cell and BM banks together with high treatment expenses are the 
main factors contributing to poor treatment processes in Iran, which are far from worldwide standards.
The use of novel currently methods used in developed countries for leukemia treatment, financial and 
psychological support of patients under treatment , making underprivileged provinces well-equipped 
,balanced  specialist service distribution relative to capital city either in diagnosis or treatment are factors 
which makes system standardized. Moreover, integrated institutional work in relation to leukemia incidence 
and statistical analysis of mortality and morbidity rate can pave the way for reducing and eliminating the 
problems in diagnosis and treatment of leukemia patients. 
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INTRODUCTION
    The uncontrollable effects of malignant 
diseases and those mental and economical effects 
on a society is well obvious, and currently they 
considered as one of the most significant health 
problems in the world [1]. It can be stated that 
malignancies are the second and third cause of 
mortality in developed and underdeveloped 
countries, respectively [2]. It is estimated that 
with uncontrollable growth of human exposure to 
environmental risk factors, we will observe the 
higher incidence of cancers in the following 
years, as a result, the chance for develop the 
cancer for each person would be 50% to 60% in 
2050 [3].Statistically, as most countries in the 
world, the rate of cancers in Iran is increasing. In 
some cases this prevalence is higher than the 
standard levels [4]. according to the Iran ministry 
of health report published by 2007 ( based on the 
report of Pathology center, exclusively), cancers
of skin,  breast, stomach, colorectal, liver, 
hematopoietic system, esophagus, prostate, lung, 
brain, and the central nervous system (CNS) are 
the most prevalent malignancies in Iran [3]. 
among these, hematological malignancies with 
5.7% incidence ranked sixth , showing 1.3
increase relative to 2005 report. Currently based 
on the standards of  health organizations, 
